Oncology & Hematology Coding Alert

Understand documentation requirements, administration codes, infusion timing, and more.

Oncology infusion coding is often complex and confusing. It involves accurate reporting of chemotherapy administration, immunotherapy, and other related medications provided in an infusion setting. This can be performed in places such as hospitals, outpatient clinics, and physicians’ offices.

To accurately report infusions, medical coders must have an extensive understanding of the chemotherapy administration codes (96401-96549) and the drug codes located in HCPCS Level II code book (the J and Q codes) used to report the medications. Proper coding also requires careful review of documentation to determine the route of administration, method of delivery, and the timing and sequence of drugs administered. Correct coding of oncology infusions is essential to ensure compliant billing and quick reimbursement.

Begin by Understanding Physician Requirements

Physician documentation must be complete and detailed to ensure compliant infusion administration and coding, according to the Accreditation Commission for Health Care. Prior to initiating any infusion, the treating physician must create a treatment order and plan. These documents need to support the medical necessity for treatment, the patient’s diagnosis (including stage when appropriate), treatment plan, specific drug name, dosage, route of administration, frequency, and duration of treatment (for example, see the drugs, biologicals and injections documentation requirement checklist provided by Medicare Administrative Contractor [MAC] Noridian).

Providers need to create a written order that includes the cycle of treatment. This is particularly important for patients who are undergoing protocols requiring multiple treatment cycles. Additionally, providers need to regularly document patient assessments, laboratory results, and confirm that patients meet clinical criteria to receive their infusions. Physician orders and documentation are essential because they are the foundation for the infusion. They allow coders and nursing staff to verify the correct medications, confirm medical necessity, and ensure the appropriate HCPCS Level II codes and related services are assigned.

Then Look to Nursing Requirements

Nursing documentation is also key in supporting accurate oncology infusion coding. This ensures that the services provided to the patient are reflected in the medical record. These team members are responsible for documenting the key details related to the infusion, which includes the medication administered, dosage, route, and method of delivery, such as intravenous (IV) infusion, IV push, or injection, according to Open RN’s Nursing Skills textbook.

This record must include the start and stop times for each infusion, which access site was used, and the order in which the nurse administered the medications. This is important when the patient receives chemotherapy drugs along with supportive medications such as antiemetics or hydration. Additionally, nurses must document patient monitoring, tolerance to the infusion, and any adverse reactions during treatment.

All of this documentation allows coders to have the required information to apply the correct CPT^® and HCPCS Level II codes while supporting compliance and proper reimbursement.

Then Apply CPT^® Codes

Using physician and nursing documentation, coders must follow CPT^® time reporting rules for infusion services. That means using the appropriate code such as 96413 (Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug) for the first 60 minutes of infusion time.

If the infusion goes beyond 60 minutes, you should use add-on codes such as +96415 (… each additional hour (List separately in addition to code for primary procedure)) for each additional hour. However, you can only apply the add-on code when the infusion exceeds 30 minutes beyond the initial hour of the administration. For example, if the chemotherapy infusion lasts 1 hour and 15 minutes, you should report only the initial code. However, if the chemotherapy infusion lasts 1 hour and 32 minutes, report the initial hour plus one add-on code (see, for example, the Centers for Medicare & Medicaid Services (CMS) article “Billing and Coding: Infusion, Injection and Hydration Services” and Noridian’s “Chemotherapy and Nonchemotherapy”).

Level up Your HCPCS Level II Coding

Oncology infusions often involve multiple medications administered during the same visit and are coded using HCPCS Level II codes, usually J codes, which typically identify injectable drugs. Injectable chemotherapy, supportive medications, and hydration solutions are assigned specific HCPCS Level II codes that represent the name of the drug and billing unit/dose. You determine the number of units billed by calculating the dose given to the patient relative to the HCPCS Level II code descriptor. For example, suppose a nurse gives a patient 8 mg of the drug Zofran. Per the descriptor for J2405 (Injection, ondansetron hydrochloride, per 1 mg), the billed units would be 8.

Take note: It is imperative coders ensure the correct HCPCS drug codes and units are reported for each medication.

Know Biologics and Biosimilars

There are many biologic drugs used in oncology. These medications are complex therapies derived from living organisms and are used to target specific cancer pathways. Examples are treatments such as monoclonal antibodies and other targeted therapies used in chemotherapy regimens.

Biologics are costly to develop and manufacture. As a result, biosimilar drugs have been introduced as a safe, more affordable option, according to the U.S. Food and Drug Administration (FDA). Biosimilars are also FDA-approved and must demonstrate no clinical difference in safety, purity, or effectiveness. Biologics and biosimilars have their own unique HCPCS Level II drug codes. This is important because reimbursement, units, and payer policies are different between the two. Common biologic and biosimilar drugs used in oncology include the following:

Mind These Modifiers

When coding for chemotherapy and other injectable oncology medications, it is important to account for drug wastage when only a portion of a single-dose vial is used. Medicare and payers following Medicare rules require you to use modifier JW (Drug amount discarded/not administered to any patient) to support the amount of the drug that is wasted and not administered. The wasted amount must be documented in the medical record and billed to the payer on a separate claim line to support this amount.

On the other side, if no wastage occurred, Medicare requires you to report modifier JZ (Zero drug amount discarded/not administered to any patient) on the billing line to support there is no portion discarded.

Example of reporting JW: If a 100 mg vial of a drug is used to administer 95 mg, bill 95 units on Line 1 and 5 units on Line 2, along with JW, like this:

Line 1 (Administered) HCPCS code, 95 units, no modifier

Line 2 (Wasted) HCPCS code, 5 units, JW modifier

Example of reporting JZ: Code J1745 (Injection, infliximab, excludes biosimilar, 10 mg) covers each 10 mg of Remicade administered. If 490 mg were given, you would calculate 490/10=49 units. Line 1 is filled in with J1745, the units administered (49), and the JZ modifier (no waste).

Avoid These Common Oncology Infusion Coding Errors

Oncology infusion coding can be complicated. Chemotherapy encounters frequently involve multiple medications and administration methods, in addition to time-based billing and coding requirements. It is important for coders to remember the chemotherapy administration hierarchy, in which chemotherapy takes priority in coding over therapeutic or hydration infusions. Coders may also inadvertently report multiple initial infusion codes for the same access site when only one initial service is appropriate, according to “Tips on Chemotherapy and Therapeutic Infusions and Injections,” published by the National Alliance of Medical Auditing Specialists.

Other errors include incorrect calculation of infusion time when multiple infusions occur on the same date, incorrect reporting of a drug, failure to report drug wastage, and confusion between IV push and infusion services.

And Bear in Mind This Final Advice

Oncology infusion coding requires a strong understanding of the complex anatomy involved in cancer treatment and the more challenging services and guidelines involved in cancer treatment. Coders are responsible for taking physician and nursing documentation to apply the correct CPT^® and HCPCS Level II codes, as well as the ICD-10-CM codes that support medical necessity.

Careful attention to details, including the route of administration, infusion timing, sequencing of medications, drug units, and appropriate modifier use, is essential to ensure compliant and accurate billing.

Next month, we’ll give you a chance to put your newfound infusion coding knowledge to the test as we invite you to code four challenging clinical scenarios. Stay tuned!

Amanda Donoho, MA, CPC, COC, CPMA, CRC, Senior Audit Educator, Facility Audit, Compliance & Litigation Services and Jennifer Methax, CPC, Senior Coding Specialist, Specialty Service Models & Risk Adjustment, Pinnacle Enterprise Risk Consulting Services